Serratia infections in a general hospital: Characteristics and outcomes

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 5, 2011, Pages 653-660

  Samonis, G ^a   Vouloumanou, E K ^b   Christofaki, M ^a   Dimopoulou, D ^a   Maraki, S ^a   Triantafyllou, E ^b,c   Kofteridis, D P ^a   Falagas, M E ^b,d,e  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^c NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

^d HENRY DUNANT HOSPITAL   (Greece)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; NALIDIXIC ACID; NETILMICIN; NITROFURANTOIN; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TICARCILLIN; TIMENTIN; TOBRAMYCIN; TRIMETHOPRIM; UNINDEXED DRUG;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CAUSE OF DEATH; CONTROLLED STUDY; ENDOPHTHALMITIS; FEMALE; GENERAL HOSPITAL; HOSPITAL INFECTION; HUMAN; INFANT; KERATITIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; SERRATIA INFECTION; SERRATIA MARCESCENS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CROSS INFECTION; ENDOPHTHALMITIS; GREECE; HOSPITALS, GENERAL; HUMANS; KERATITIS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SERRATIA INFECTIONS; SERRATIA MARCESCENS; TREATMENT OUTCOME;

EID: 79956107918     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-010-1135-4     Document Type: Article

References (52)

1. Chemaly RF, Rathod DB, Raad II (2009) A tertiary care cancer center experience of the 2007 outbreak of Serratia marcescens bloodstream infection due to prefilled syringes. Infect Control Hosp Epidemiol 30:1237-1238
2. Kim JH, Choi WH, Yun SW, Chae SA, Yoo BH (2010) An outbreak of Serratia marcescens Sepsis in a pediatric ward. Clin Pediatr (Phila) 49(10):1000-1002
3. Arslan U, Erayman I, Kirdar S et al (2010) Serratia marcescens sepsis outbreak in a neonatal intensive care unit. Pediatr Int 52:208-212
4. Dessi A, Puddu M, Testa M, Marcialis MA, Pintus MC, Fanos V (2009) Serratia marcescens infections and outbreaks in neonatal intensive care units. J Chemother 21:493-499
5. Voelz A, Muller A, Gillen J et al (2010) Outbreaks of Serratia marcescens in neonatal and pediatric intensive care units: clinical aspects, risk factors and management. Int J Hyg Environ Health 213:79-87
6. Pinna A, Usai D, Sechi LA, Carta A, Zanetti S (2009) Detection of virulence factors in Serratia strains isolated from contact lens-associated corneal ulcers. Acta Ophthalmol [Epub ahead of print]
7. Szczotka-Flynn LB, Imamura Y, Chandra J et al (2009) Increased resistance of contact lens-related bacterial biofilms to antimicrobial activity of soft contact lens care solutions. Cornea 28:918-926
8. Laupland KB, Parkins MD, Gregson DB, Church DL, Ross T, Pitout JD (2008) Population-based laboratory surveillance for Serratia species isolates in a large Canadian health region. Eur J Clin Microbiol Infect Dis 27:89-95 (Pubitemid 351171513)
9. Dalamaga M, Pantelaki M, Karmaniolas K, Matekovits A, Daskalopoulou K (2008) Cutaneous abscess and bacteremia due to Serratia ficaria. J Eur Acad Dermatol Venereol 22:1388-1389
10. Dubouix A, Roques C, Segonds C et al (2005) Epidemiological investigation of a Serratia liquefaciens outbreak in a neurosurgery department. J Hosp Infect 60:8-13 (Pubitemid 40485844)
11. Grohskopf LA, Roth VR, Feikin DR et al (2001) Serratia liquefaciens bloodstream infections from contamination of epoetin alfa at a hemodialysis center. N Engl J Med 344:1491-1497 (Pubitemid 32429207)
12. Mostafa E, Mohammed F, Abdelhamid Z, Tahar B, Sakina E, Belkacem C (2008) Septic pseudarthrosis caused by Serratia plymuthica. Joint Bone Spine 75:506-507
13. Crivaro V, Bagattini M, Salza MF et al (2007) Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Hosp Infect 67:135-141 (Pubitemid 47534972)
14. Mlynarczyk A, Szymanek K, Sawicka-Grzelak A et al (2009) CTX-M and TEM as predominant types of extended spectrum beta-lactamases among Serratia marcescens isolated from solid organ recipients. Transplant Proc 41:3253-3255
15. Rizvi M, Fatima N, Shukla I, Malik A (2010) Epidemiology of extended spectrum beta-lactamases in Serratia and Citrobacter species in North India. Indian J Pathol Microbiol 53:193-194
16. Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Kapaskelis A, Samonis G (2010) Antimicrobial susceptibility of Gram-positive non-urinary isolates to fosfomycin. Int J Antimicrob Agents 35:497-499
17. Falagas ME, Maraki S, Karageorgopoulos DE, Kastoris AC, Mavromanolakis E, Samonis G (2010) Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents 35:240-243
18. Maraki S, Samonis G, Rafailidis PI, Vouloumanou EK, Mavromanolakis E, Falagas ME (2009) Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob Agents Chemother 53:4508-4510
19. Samonis G, Maraki S, Rafailidis PI, Kapaskelis A, Kastoris AC, Falagas ME (2010) Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials. Future Microbiol 5:961-970
20. Samonis G, Matthaiou DK, Kofteridis D, Maraki S, Falagas ME (2010) In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece. Clin Infect Dis 50:1689-1691
21. Farmer JJ III, Boatwright KD, Janda JM (2007) Enterobacteriaceae: Introduction and identification. In: Murray P, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA (eds) Manual of clinical microbiology, vol 1, 9th edn. American Society for Microbiology, Washington, pp 649-669
22. Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing; Nineteenth informational supplement. CLSI Document M100-S19, Wayne, PA, USA
23. Dean A, Sullivan K, Soe M (2008) OpenEpi: open source epidemiologic statistics for public health, version 2.2.1. Updated 2008/04/06. Available from: www.OpenEpi.com. Cited 18 September 2008
24. Engel HJ, Collignon PJ, Whiting PT, Kennedy KJ (2009) Serratia sp. bacteremia in Canberra, Australia: a population-based study over 10 years. Eur J Clin Microbiol Infect Dis 28:821-824
25. Rice SA, Koh KS, Queck SY, Labbate M, Lam KW, Kjelleberg S (2005) Biofilm formation and sloughing in Serratia marcescens are controlled by quorum sensing and nutrient cues. J Bacteriol 187:3477-3485 (Pubitemid 40628704)
26. Van Houdt R, Givskov M, Michiels CW (2007) Quorum sensing in Serratia. FEMS Microbiol Rev 31:407-424 (Pubitemid 46920249)
27. Molina-Cabrillana J, Rodriguez-Bermejo JC, del Rosario-Quintana C, Bolanos-Rivero M (2007) Rapid detection of an outbreak of bronchoscopy- associated colonization by Serratia marcescens. Enferm Infecc Microbiol Clín 25:222-224 (Pubitemid 46548470)
28. Jones GL, Muller CT, O'Reilly M, Stickler DJ (2006) Effect of triclosan on the development of bacterial biofilms by urinary tract pathogens on urinary catheters. J Antimicrob Chemother 57:266-272
29. Horcajada JP, Martinez JA, Alcon A et al (2006) Acquisition of multidrug-resistant Serratia marcescens by critically ill patients who consumed tap water during receipt of oral medication. Infect Control Hosp Epidemiol 27:774-777 (Pubitemid 44271965)
30. de Vries JJ, Baas WH, van der Ploeg K, Heesink A, Degener JE, Arends JP (2006) Outbreak of Serratia marcescens colonization and infection traced to a healthcare worker with long-term carriage on the hands. Infect Control Hosp Epidemiol 27:1153-1158 (Pubitemid 44807456)
31. Casolari C, Pecorari M, Fabio G et al (2005) A simultaneous outbreak of Serratia marcescens and Klebsiella pneumoniae in a neonatal intensive care unit. J Hosp Infect 61:312-320 (Pubitemid 43009076)
32. Johnson JS, Croall J, Power JS, Armstrong GR (1998) Fatal Serratia marcescens meningitis and myocarditis in a patient with an indwelling urinary catheter. J Clin Pathol 51:789-790 (Pubitemid 28480339)
33. Kim BN, Choi SI, Ryoo NH (2006) Three-year follow-up of an outbreak of Serratia marcescens bacteriuria in a neurosurgical intensive care unit. J Korean Med Sci 21:973-978
34. Yu WL, Lin CW, Wang DY (1998) Serratia marcescens bacteremia: clinical features and antimicrobial susceptibilities of the isolates. J Microbiol Immunol Infect 31:171-179
35. Parment PA (1997) The role of Serratia marcescens in soft contact lens associated ocular infections. A review. Acta Ophthalmol Scand 75:67-71
36. Latorre G (2008) Endogenous Serratia marcescens endophthalmitis in a preterm infant. Indian J Pediatr 75:410
37. Mah-Sadorra JH, Najjar DM, Rapuano CJ, Laibson PR, Cohen EJ (2005) Serratia corneal ulcers: a retrospective clinical study. Cornea 24:793-800 (Pubitemid 41400417)
38. Chuang TY, Chuang CP, Cheng HH, Hsueh PR (2007) Aortic valve infective endocarditis caused by Serratia liquefaciens. J Infect 54:e161-e163
39. Sekhsokh Y, Arsalane L, El Ouenass M, Doublali T, Bajjou T, Lahlou Amine I (2007) Serratia rubidaea bacteremia. Méd Mal Infect 37:287-289
40. Okada T, Yokota E, Matsumoto I (2002) Community acquired sepsis by Serratia rubidaea. Kansenshogaku Zasshi 76:109-112
41. Anahory T, Darbas H, Ongaro O, Jean-Pierre H, Mion P (1998) Serratia ficaria: a misidentified or unidentified rare cause of human infections in fig tree culture zones. J Clin Microbiol 36:3266-3272 (Pubitemid 28476177)
42. Liu J-W, Hsu Y-M, Huang Y-F (2004) Independent prognostic factors for fatality in patients with urinary tract infection caused by Serratia marcescens. Infect Control Hosp Epidemiol 25:80-82 (Pubitemid 38139851)
43. Cheng K-C, Chuang Y-C, Wu L-T, Huang G-C, Yu W-L (2006) Clinical experiences of the infections caused by extended-spectrum beta-lactamase- producing Serratia marcescens at a medical center in Taiwan. Jpn J Infect Dis 59:147-152 (Pubitemid 43959970)
44. Park YJ, Park SY, Oh EJ et al (2005) Occurrence of extended-spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria. Diagn Microbiol Infect Dis 51:265-269
45. Rizvi M, Fatima N, Rashid M et al (2009) Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay. J Infect Dev Ctries 3:285-294
46. Kumamoto Y, Tsukamoto T, Matsukawa M et al (2005) Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). I. Susceptibility distribution. Jpn J Antibiot 58:518-543
47. Tsou MF, Yu WL, Hung SW et al (2004) Detection of cefotaxime-resistant CTX-M-3 in clinical isolates of Serratia marcescens. Folia Microbiol (Praha) 49:452-456
48. Zhao WH, Hu ZQ, Chen G, Matsushita K, Fukuchi K, Shimamura T (2007) Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid. Microbiol Res 162:46-52 (Pubitemid 46073686)
49. Sheng WH, Chen YC, Wang JT, Chang SC, Luh KT, Hsieh WC (2002) Emerging fluoroquinolone-resistance for common clinically important gram-negative bacteria in Taiwan. Diagn Microbiol Infect Dis 43:141-147
50. Acar JF, O'Brien TF, Goldstein FW, Jones RN (1993) The epidemiology of bacterial resistance to quinolones. Drugs 45 (Suppl 3):24-28 (Pubitemid 23242911)
51. Velasco C, Rodriguez-Martinez JM, Briales A, Diaz de Alba P, Calvo J, Pascual A (2010) Smaqnr, a new chromosome-encoded quinolone resistance determinant in Serratia marcescens. J Antimicrob Chemother 65:239-242
52. Falagas ME, Karageorgopoulos DE (2009) Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect 73:345-354